On this page

PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue

API Holdings, parent of online pharmacy PharmEasy, has withdrawn its Rs 6,250 crore DRHP filed with SEBI in 2021 and is weighing a rights issue to existing shareholders to raise capital amid weak market conditions for new-age listings.

Reported figures

From the report. Source details below

  • Rs 4,546 crore Thyrocare acquisition

Other figures

  • board met August 19

The source

Source Read the source at Moneycontrol Filed

First seen

By

Note Information, not investment advice. RetailIntel is not registered with SEBI.